[go: up one dir, main page]

FR2984129B1 - Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des etats pelliculaires du cuir chevelu - Google Patents

Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des etats pelliculaires du cuir chevelu

Info

Publication number
FR2984129B1
FR2984129B1 FR1161621A FR1161621A FR2984129B1 FR 2984129 B1 FR2984129 B1 FR 2984129B1 FR 1161621 A FR1161621 A FR 1161621A FR 1161621 A FR1161621 A FR 1161621A FR 2984129 B1 FR2984129 B1 FR 2984129B1
Authority
FR
France
Prior art keywords
scalp
prevention
treatment
polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1161621A
Other languages
English (en)
Other versions
FR2984129A1 (fr
Inventor
Audrey Gueniche
Isabelle Castiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1161621A priority Critical patent/FR2984129B1/fr
Priority to PCT/IB2012/057242 priority patent/WO2013088371A2/fr
Publication of FR2984129A1 publication Critical patent/FR2984129A1/fr
Application granted granted Critical
Publication of FR2984129B1 publication Critical patent/FR2984129B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24065—Macrophage elastase (3.4.24.65), i.e. metalloelastase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne l'utilisation cosmétique d'une quantité efficace d'au moins un actif consistant en un polypeptide ayant au moins 80 % d'identité en acides aminés avec une métalloprotéinase MMP-12 de séquence choisie parmi SEQ ID NO: 1, SEQ ID NO: 2 et SEQ ID NO: 3, ou un fragment C-terminal dudit polypeptide, pour prévenir et/ou traiter les états pelliculaires du cuir chevelu, ledit polypeptide ou ledit fragment comprenant la séquence KDXK, dans laquelle X représente l'acide aspartique ou l'acide glutamique
FR1161621A 2011-12-14 2011-12-14 Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des etats pelliculaires du cuir chevelu Active FR2984129B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1161621A FR2984129B1 (fr) 2011-12-14 2011-12-14 Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des etats pelliculaires du cuir chevelu
PCT/IB2012/057242 WO2013088371A2 (fr) 2011-12-14 2012-12-12 Utilisation de la protéine mmp-12 dans la prévention et/ou le traitement d'états pélliculaires du cuir chevelu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1161621A FR2984129B1 (fr) 2011-12-14 2011-12-14 Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des etats pelliculaires du cuir chevelu

Publications (2)

Publication Number Publication Date
FR2984129A1 FR2984129A1 (fr) 2013-06-21
FR2984129B1 true FR2984129B1 (fr) 2014-01-10

Family

ID=45926673

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1161621A Active FR2984129B1 (fr) 2011-12-14 2011-12-14 Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des etats pelliculaires du cuir chevelu

Country Status (2)

Country Link
FR (1) FR2984129B1 (fr)
WO (1) WO2013088371A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114788791A (zh) 2017-06-23 2022-07-26 宝洁公司 用于改善皮肤外观的组合物和方法
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2021247496A1 (fr) 2020-06-01 2021-12-09 The Procter & Gamble Company Méthode d'amélioration de la pénétration d'un composé de vitamine b3 dans la peau

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030235577A1 (en) * 2002-04-08 2003-12-25 Shapiro Steven D. Methods and compositions for preventing and treating microbial infections
DE10324567A1 (de) 2003-05-30 2004-12-23 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als antimikrobielle Wirkstoffe
TWI395593B (zh) * 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制

Also Published As

Publication number Publication date
WO2013088371A3 (fr) 2013-12-27
FR2984129A1 (fr) 2013-06-21
WO2013088371A2 (fr) 2013-06-20

Similar Documents

Publication Publication Date Title
RU2498988C2 (ru) Ингибиторы активности протеинтирозинкиназы
EA201000441A1 (ru) Водные офтальмологические препараты
EP2532365A4 (fr) Composition pharmaceutique pour le traitement et/ou la prévention du cancer
EA200971053A1 (ru) Способы лечения кожных язв
BR112012018246A2 (pt) compostos de amida reversa como inibidores de proteína desacetilase e métodos de uso destes
CO6230997A2 (es) Proteinas de union a antigeno contra proproteina convertasa subtilisina/kexina tipo 9 (pcsk9)
MA31862B1 (fr) Anticorps anti-mésothéline et leurs utilisations
EA201500802A1 (ru) Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы
HRP20110242T1 (hr) Formulacija s fuzijskim proteinom glp-1-fc
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
MA41759A (fr) Inclusion de l'exon 2, induite par antisens, dans une alpha-glucosidase acide
MA32539B1 (fr) Traitement du diabète chez des patients pour lesquels une thérapie par la metformine n'est pas appropriée
FR2984129B1 (fr) Utilisation de la proteine mmp-12 dans la prevention et/ou le traitement des etats pelliculaires du cuir chevelu
MA32132B1 (fr) Utilisation de ranolazine pour traiter la douleur
JP2013542919A5 (fr)
MX2021006253A (es) Terapias génicas para enfermedad neurodegenerativa.
WO2019045248A3 (fr) Peptide présentant une activité d'atténuation des rides et utilisations associées
EA201391006A1 (ru) Гипотоническая водная композиция с пониженным содержанием хлора и с или без фосфолипидов
EA202190888A1 (ru) Пептид для применения в косметике
MY205028A (en) Protein for treatment of inflammatory diseases
EA201300062A1 (ru) Фармацевтическая композиция, предназначенная для лечения заболеваний центральной и периферической нервной системы сосудистого, травматического, токсического, гипоксического и аутоиммунного генеза
MX394323B (es) Uso de una composición antibacteriana para tratar infecciones por estafilococos.
MX344183B (es) Proteina antimicrobiana.
FR2942720B1 (fr) Utilisation cosmetique d'hesperidine.
EA202090802A1 (ru) Пептидная композиция для лечения повреждений, связанных с возбуждающей нейротоксичностью

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13